NM_001355436.2:c.4860T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.4860T>C​(p.Ile1620Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.284 in 1,553,578 control chromosomes in the GnomAD database, including 73,904 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 16309 hom., cov: 32)
Exomes 𝑓: 0.27 ( 57595 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.24

Publications

20 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 14-64774510-A-G is Benign according to our data. Variant chr14-64774510-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.745 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.4860T>C p.Ile1620Ile synonymous_variant Exon 24 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.4860T>C p.Ile1620Ile synonymous_variant Exon 24 of 36 NM_001355436.2 ENSP00000495909.1 P11277-2
SPTBENST00000553938.5 linkc.855T>C p.Ile285Ile synonymous_variant Exon 5 of 18 1 ENSP00000451324.1 H0YJE6
SPTBENST00000389722.7 linkc.4860T>C p.Ile1620Ile synonymous_variant Exon 23 of 35 2 ENSP00000374372.3 P11277-2
SPTBENST00000389720.4 linkc.4860T>C p.Ile1620Ile synonymous_variant Exon 24 of 32 5 ENSP00000374370.4 P11277-1

Frequencies

GnomAD3 genomes
AF:
0.410
AC:
62253
AN:
151850
Hom.:
16267
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.751
Gnomad AMI
AF:
0.243
Gnomad AMR
AF:
0.328
Gnomad ASJ
AF:
0.278
Gnomad EAS
AF:
0.464
Gnomad SAS
AF:
0.316
Gnomad FIN
AF:
0.342
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.374
GnomAD2 exomes
AF:
0.324
AC:
51720
AN:
159502
AF XY:
0.315
show subpopulations
Gnomad AFR exome
AF:
0.764
Gnomad AMR exome
AF:
0.325
Gnomad ASJ exome
AF:
0.284
Gnomad EAS exome
AF:
0.467
Gnomad FIN exome
AF:
0.341
Gnomad NFE exome
AF:
0.245
Gnomad OTH exome
AF:
0.319
GnomAD4 exome
AF:
0.270
AC:
378130
AN:
1401610
Hom.:
57595
Cov.:
35
AF XY:
0.269
AC XY:
186176
AN XY:
691638
show subpopulations
African (AFR)
AF:
0.776
AC:
24633
AN:
31752
American (AMR)
AF:
0.328
AC:
11831
AN:
36094
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
7131
AN:
25190
East Asian (EAS)
AF:
0.489
AC:
17609
AN:
35998
South Asian (SAS)
AF:
0.298
AC:
23645
AN:
79406
European-Finnish (FIN)
AF:
0.335
AC:
16408
AN:
49008
Middle Eastern (MID)
AF:
0.308
AC:
1754
AN:
5694
European-Non Finnish (NFE)
AF:
0.238
AC:
257171
AN:
1080350
Other (OTH)
AF:
0.309
AC:
17948
AN:
58118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
16401
32802
49202
65603
82004
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9090
18180
27270
36360
45450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.410
AC:
62356
AN:
151968
Hom.:
16309
Cov.:
32
AF XY:
0.412
AC XY:
30624
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.752
AC:
31163
AN:
41460
American (AMR)
AF:
0.328
AC:
5017
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
966
AN:
3472
East Asian (EAS)
AF:
0.466
AC:
2387
AN:
5126
South Asian (SAS)
AF:
0.314
AC:
1512
AN:
4820
European-Finnish (FIN)
AF:
0.342
AC:
3615
AN:
10564
Middle Eastern (MID)
AF:
0.357
AC:
105
AN:
294
European-Non Finnish (NFE)
AF:
0.244
AC:
16576
AN:
67926
Other (OTH)
AF:
0.376
AC:
794
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1537
3074
4611
6148
7685
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
548
1096
1644
2192
2740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.305
Hom.:
29624
Bravo
AF:
0.430
Asia WGS
AF:
0.414
AC:
1440
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 28, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 22, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spherocytosis type 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
1.9
DANN
Benign
0.60
PhyloP100
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs229592; hg19: chr14-65241228; COSMIC: COSV67630256; API